Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 47308-47309 [2017-21897]
Download as PDF
47308
Federal Register / Vol. 82, No. 195 / Wednesday, October 11, 2017 / Notices
for the crash was assigned to the rental
truck driver.
Terms and Conditions of the Exemption
Terms of the Exemption
• This exemption from the
requirements of 49 CFR 395.8(a)(1)(i) is
effective from October 11, 2017 through
October 11, 2022.
• This exemption covers a rental
period of 8 days or fewer, regardless of
reason for the rental. Evidence that a
carrier has replaced one rental CMV
with another on 8-day cycles or
attempted to renew a rental agreement
for the same CMV for an additional 8
days will be regarded as a violation of
the exemption and subject the carrier to
the penalties for failure to use an ELD.
• Drivers must have a copy of this
notice or equivalent signed FMCSA
exemption document in their possession
while operating under the terms of the
exemption. The exemption document
must be presented to law enforcement
officials upon request.
• Drivers must have a copy of the
rental agreement in the CMV, and make
it available to law enforcement officers
on request. The agreement must clearly
identify the parties to the agreement, the
vehicle, and the dates of the rental
period.
• Driver must possess copies of their
RODS for the current day and the prior
7 days, if required on those days.
Preemption
In accordance with 49 U.S.C.
31313(d), as implemented by 49 CFR
381.600, during the period this
exemption is in effect, no State shall
enforce any law or regulation applicable
to interstate commerce that conflicts
with or is inconsistent with this
exemption with respect to a firm or
person operating under the exemption.
States may, but are not required to,
adopt the same exemption with respect
to operations in intrastate commerce.
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Notification to FMCSA
Carriers operating under this
exemption must notify FMCSA within 5
business days of any accident (as
defined in 49 CFR 390.5), involving any
of the motor carrier’s drivers operating
under the terms of this exemption. The
notification must include the following
information:
(a) Identity of Exemption: ‘‘TRALA’’
(b) Date of the accident,
(c) City or town, and State, in which
the accident occurred, or closest to the
accident scene,
(d) Driver’s name and license number,
(e) Co-driver’s name and license
number,
VerDate Sep<11>2014
17:58 Oct 10, 2017
Jkt 244001
(f) Vehicle number and State license
number,
(g) Number of individuals suffering
physical injury,
(h) Number of fatalities,
(i) The police-reported cause of the
accident,
(j) Whether the driver was cited for
violation of any traffic laws, motor
carrier safety regulations, and
(k) The total driving time and total onduty time period prior to the accident.
Accident notifications shall be
emailed to MCPSD@dot.gov.
Termination
FMCSA believes that drivers of shortterm rental vehicles will continue to
maintain their previous safety record
while operating under this exemption.
However, should problems occur,
FMCSA will take all steps necessary to
protect the public interest, including
revocation or restriction of the
exemption. FMCSA will immediately
restrict participation in the exemption
for failure to comply with its terms and
conditions.
Issued on: September 28, 2017.
Daphne Y. Jefferson,
Deputy Administrator.
[FR Doc. 2017–21892 Filed 10–10–17; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2017–0038]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt 47 individuals from
the prohibition in the Federal Motor
Carrier Safety Regulations (FMCSRs)
against persons with insulin-treated
diabetes mellitus (ITDM) from operating
a commercial motor vehicle (CMV) in
interstate commerce. The exemptions
enable these individuals with ITDM to
operate CMVs in interstate commerce.
DATES: The exemptions were applicable
on August 29, 2017. The exemptions
expire on August 29, 2019.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200
New Jersey Avenue SE., Room W64–
224, Washington, DC 20590–0001.
SUMMARY:
PO 00000
Frm 00138
Fmt 4703
Sfmt 4703
Office hours are from 8:30 a.m. to 5
p.m., e.t., Monday through Friday,
except Federal holidays. If you have
questions regarding viewing or
submitting material to the docket,
contact Docket Services, telephone (202)
366–9826.
SUPPLEMENTARY INFORMATION:
I. Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., e.t., Monday through Friday,
except Federal holidays.
Privacy Act: In accordance with 5
U.S.C. 553(c), DOT solicits comments
from the public to better inform its
rulemaking process. DOT posts these
comments, without edit, including any
personal information the commenter
provides, to https://www.regulations.gov,
as described in the system of records
notice (DOT/ALL–14 FDMS), which can
be reviewed at https://www.dot.gov/
privacy.
II. Background
On July 27, 2017, FMCSA published
a notice announcing receipt of
applications from 47 individuals
requesting an exemption from diabetes
requirement in 49 CFR 391.41(b)(3) and
requested comments from the public (82
FR 35033). The public comment period
ended on August 28, 2017, and two
comments were received.
FMCSA has evaluated the eligibility
of these applicants and determined that
granting the exemptions to these
individuals would achieve a level of
safety equivalent to or greater than the
level that would be achieved by
complying with the current regulation
49 CFR 391.41(b)(3).
The physical qualification standard
for drivers regarding diabetes found in
49 CFR 391.41(b)(3) states that a person
is physically qualified to drive a CMV
if that person:
Has no established medical history or
clinical diagnosis of diabetes mellitus
currently requiring insulin for control.
III. Discussion of Comments
FMCSA received two comments in
this proceeding. Givonna Hymel stated
that she believes the exemption
application process should be
shortened, and that the program in its
current form is unfair and
E:\FR\FM\11OCN1.SGM
11OCN1
Federal Register / Vol. 82, No. 195 / Wednesday, October 11, 2017 / Notices
asabaliauskas on DSKBBXCHB2PROD with NOTICES
discriminatory. On May 4, 2015,
FMCSA published a Notice of Proposed
Rulemaking (NPRM) (80 FR 25260)
proposed changes to the Diabetes
standard and requesting comments from
the public. FMCSA is currently
evaluating comments received and
drafting a Final Rule. Information
related to this action can be found in the
Docket at FMCSA–2005–23151. Marisol
Aguilar stated that she agrees with the
decision to grant exemptions to Mark A.
Brede, Bradley J. Holmstrom, Delbert E.
Holt, and Anthony A. Kronbeck.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes standard in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
The Agency’s decision regarding these
exemption applications is based on the
program eligibility criteria and an
individualized assessment of
information submitted by each
applicant. The qualifications,
experience, and medical condition of
each applicant were stated and
discussed in detail in the July 27, 2017,
Federal Register notice (85 FR 35033)
and will not be repeated in this notice.
These 47 applicants have had ITDM
over a range of one to 42 years. These
applicants report no severe
hypoglycemic reactions resulting in loss
of consciousness or seizure, requiring
the assistance of another person, or
resulting in impaired cognitive function
that occurred without warning
symptoms, in the past 12 months and no
recurrent (two or more) severe
hypoglycemic episodes in the past five
years. In each case, an endocrinologist
verified that the driver has
demonstrated a willingness to properly
monitor and manage his/her diabetes
mellitus, received education related to
diabetes management, and is on a stable
insulin regimen. These drivers report no
other disqualifying conditions,
including diabetes related
complications. Each meets the vision
requirement at 49 CFR 391.41(b)(10).
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes requirement in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
IV. Conditions and Requirements
The terms and conditions of the
exemption are provided to the
applicants in the exemption document
VerDate Sep<11>2014
17:58 Oct 10, 2017
Jkt 244001
and includes the following: (1) Each
driver must submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) each driver must
report within two business days of
occurrence, all episodes of severe
hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) each driver must
provide a copy of the ophthalmologist’s
or optometrist’s report to the Medical
Examiner at the time of the annual
medical examination; and (4) each
driver must provide a copy of the
annual medical certification to the
employer for retention in the driver’s
qualification file, or keeping a copy in
his/her driver’s qualification file if he/
she is self-employed. The driver must
also have a copy of the exemption when
driving, for presentation to a duly
authorized Federal, State, or local
enforcement official.
V. Preemption
During the period the exemption is in
effect, no State shall enforce any law or
regulation that conflicts with this
exemption with respect to a person
operating under the exemption.
VI. Conclusion
Based upon its evaluation of the 47
exemption applications, FMCSA
exempts the following drivers from the
diabetes requirement in 49 CFR
391.41(b)(10), subject to the
requirements cited above:
Miguel A. Alicea (CT)
Ralph W. Boyatt (WA)
Eduard Braun (AR)
Mark A. Brede (MN)
Lawrence P. Butler (CA)
Keith T. Campbell (TX)
Larry W. Carruth (AL)
Dennis R. Carte (MO)
Steven B. Carter (NC)
Gregory L. Crawford (MI)
James D. Duvall (VT)
Reginald D. Evans (NE)
Daniel F. Foder (NY)
Daniel J. Fowler (CT)
Michael F. Greene (MA)
Cindy E. Grimes (NE)
Leo J. Hoffman, Jr. (PA)
Bradley J. Holmstrom (MN)
Delbert E. Holt (MN)
Alexander C. Jennings (NJ)
Calvin W. Johnson (WI)
Shannon E. Johnson (AZ)
Kenneth E. King (IN)
Anthony A. Kronbeck (MN)
Charles P. Lane, Jr. (AL)
PO 00000
Frm 00139
Fmt 4703
Sfmt 4703
47309
Gjasi A. Leite (GA)
Richard V. Madden (PA)
Landon H. McCuddin (SD)
Damien R. Mitchell (NC)
Steven J. Mooney (AL)
Luther G. Mumaw, Jr. (WV)
Roberto Noa (FL)
Benjamin P. Peirce (CA)
Judah G. Pira (WA)
Robert E. Racy II (OH)
Robert P. Rowean, Jr. (MA)
Wesley R. Schmid (CT)
Royal J. Schultz (NY)
Joseph B. Simon (NJ)
Andrew J. Slionski (NY)
Samuel L. Smith (NC)
Terry D. Stumpff (WA)
Manuel A. Vasquez (NJ)
Paul O. Verly (CO)
Alvin G. Welch (NY)
Damien E. Wiggins (CA)
Frank R. Woitel (NM)
In accordance with 49 U.S.C. 31136(e)
and 31315, each exemption will be valid
for two years from the effective date
unless revoked earlier by FMCSA. The
exemption will be revoked if the
following occurs: (1) The person fails to
comply with the terms and conditions
of the exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained prior to being granted;
or (3) continuation of the exemption
would not be consistent with the goals
and objectives of 49 U.S.C. 31136(e) and
31315.
Issued on: October 2, 2017.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2017–21897 Filed 10–10–17; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2017–0022]
Qualification of Drivers; Exemption
Applications; Vision
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of final disposition.
AGENCY:
FMCSA announces its
decision to exempt 22 individuals from
the vision requirement in the Federal
Motor Carrier Safety Regulations
(FMCSRs) to operate a commercial
motor vehicle (CMV) in interstate
commerce. They are unable to meet the
vision requirement in one eye for
various reasons. The exemptions enable
these individuals to operate CMVs in
interstate commerce without meeting
the vision requirement in one eye.
SUMMARY:
E:\FR\FM\11OCN1.SGM
11OCN1
Agencies
[Federal Register Volume 82, Number 195 (Wednesday, October 11, 2017)]
[Notices]
[Pages 47308-47309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-21897]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2017-0038]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt 47 individuals from the
prohibition in the Federal Motor Carrier Safety Regulations (FMCSRs)
against persons with insulin-treated diabetes mellitus (ITDM) from
operating a commercial motor vehicle (CMV) in interstate commerce. The
exemptions enable these individuals with ITDM to operate CMVs in
interstate commerce.
DATES: The exemptions were applicable on August 29, 2017. The
exemptions expire on August 29, 2019.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE., Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
e.t., Monday through Friday, except Federal holidays. If you have
questions regarding viewing or submitting material to the docket,
contact Docket Services, telephone (202) 366-9826.
SUPPLEMENTARY INFORMATION:
I. Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday,
except Federal holidays.
Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to https://www.regulations.gov, as described in
the system of records notice (DOT/ALL-14 FDMS), which can be reviewed
at https://www.dot.gov/privacy.
II. Background
On July 27, 2017, FMCSA published a notice announcing receipt of
applications from 47 individuals requesting an exemption from diabetes
requirement in 49 CFR 391.41(b)(3) and requested comments from the
public (82 FR 35033). The public comment period ended on August 28,
2017, and two comments were received.
FMCSA has evaluated the eligibility of these applicants and
determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to or greater than the level that
would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
The physical qualification standard for drivers regarding diabetes
found in 49 CFR 391.41(b)(3) states that a person is physically
qualified to drive a CMV if that person:
Has no established medical history or clinical diagnosis of
diabetes mellitus currently requiring insulin for control.
III. Discussion of Comments
FMCSA received two comments in this proceeding. Givonna Hymel
stated that she believes the exemption application process should be
shortened, and that the program in its current form is unfair and
[[Page 47309]]
discriminatory. On May 4, 2015, FMCSA published a Notice of Proposed
Rulemaking (NPRM) (80 FR 25260) proposed changes to the Diabetes
standard and requesting comments from the public. FMCSA is currently
evaluating comments received and drafting a Final Rule. Information
related to this action can be found in the Docket at FMCSA-2005-23151.
Marisol Aguilar stated that she agrees with the decision to grant
exemptions to Mark A. Brede, Bradley J. Holmstrom, Delbert E. Holt, and
Anthony A. Kronbeck.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes standard in 49 CFR 391.41(b)(3) if the exemption is
likely to achieve an equivalent or greater level of safety than would
be achieved without the exemption. The exemption allows the applicants
to operate CMVs in interstate commerce.
The Agency's decision regarding these exemption applications is
based on the program eligibility criteria and an individualized
assessment of information submitted by each applicant. The
qualifications, experience, and medical condition of each applicant
were stated and discussed in detail in the July 27, 2017, Federal
Register notice (85 FR 35033) and will not be repeated in this notice.
These 47 applicants have had ITDM over a range of one to 42 years.
These applicants report no severe hypoglycemic reactions resulting in
loss of consciousness or seizure, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning symptoms, in the past 12 months and no recurrent (two
or more) severe hypoglycemic episodes in the past five years. In each
case, an endocrinologist verified that the driver has demonstrated a
willingness to properly monitor and manage his/her diabetes mellitus,
received education related to diabetes management, and is on a stable
insulin regimen. These drivers report no other disqualifying
conditions, including diabetes related complications. Each meets the
vision requirement at 49 CFR 391.41(b)(10).
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is
likely to achieve a level of safety equal to that existing without the
exemption.
IV. Conditions and Requirements
The terms and conditions of the exemption are provided to the
applicants in the exemption document and includes the following: (1)
Each driver must submit a quarterly monitoring checklist completed by
the treating endocrinologist as well as an annual checklist with a
comprehensive medical evaluation; (2) each driver must report within
two business days of occurrence, all episodes of severe hypoglycemia,
significant complications, or inability to manage diabetes; also, any
involvement in an accident or any other adverse event in a CMV or
personal vehicle, whether or not it is related to an episode of
hypoglycemia; (3) each driver must provide a copy of the
ophthalmologist's or optometrist's report to the Medical Examiner at
the time of the annual medical examination; and (4) each driver must
provide a copy of the annual medical certification to the employer for
retention in the driver's qualification file, or keeping a copy in his/
her driver's qualification file if he/she is self-employed. The driver
must also have a copy of the exemption when driving, for presentation
to a duly authorized Federal, State, or local enforcement official.
V. Preemption
During the period the exemption is in effect, no State shall
enforce any law or regulation that conflicts with this exemption with
respect to a person operating under the exemption.
VI. Conclusion
Based upon its evaluation of the 47 exemption applications, FMCSA
exempts the following drivers from the diabetes requirement in 49 CFR
391.41(b)(10), subject to the requirements cited above:
Miguel A. Alicea (CT)
Ralph W. Boyatt (WA)
Eduard Braun (AR)
Mark A. Brede (MN)
Lawrence P. Butler (CA)
Keith T. Campbell (TX)
Larry W. Carruth (AL)
Dennis R. Carte (MO)
Steven B. Carter (NC)
Gregory L. Crawford (MI)
James D. Duvall (VT)
Reginald D. Evans (NE)
Daniel F. Foder (NY)
Daniel J. Fowler (CT)
Michael F. Greene (MA)
Cindy E. Grimes (NE)
Leo J. Hoffman, Jr. (PA)
Bradley J. Holmstrom (MN)
Delbert E. Holt (MN)
Alexander C. Jennings (NJ)
Calvin W. Johnson (WI)
Shannon E. Johnson (AZ)
Kenneth E. King (IN)
Anthony A. Kronbeck (MN)
Charles P. Lane, Jr. (AL)
Gjasi A. Leite (GA)
Richard V. Madden (PA)
Landon H. McCuddin (SD)
Damien R. Mitchell (NC)
Steven J. Mooney (AL)
Luther G. Mumaw, Jr. (WV)
Roberto Noa (FL)
Benjamin P. Peirce (CA)
Judah G. Pira (WA)
Robert E. Racy II (OH)
Robert P. Rowean, Jr. (MA)
Wesley R. Schmid (CT)
Royal J. Schultz (NY)
Joseph B. Simon (NJ)
Andrew J. Slionski (NY)
Samuel L. Smith (NC)
Terry D. Stumpff (WA)
Manuel A. Vasquez (NJ)
Paul O. Verly (CO)
Alvin G. Welch (NY)
Damien E. Wiggins (CA)
Frank R. Woitel (NM)
In accordance with 49 U.S.C. 31136(e) and 31315, each exemption
will be valid for two years from the effective date unless revoked
earlier by FMCSA. The exemption will be revoked if the following
occurs: (1) The person fails to comply with the terms and conditions of
the exemption; (2) the exemption has resulted in a lower level of
safety than was maintained prior to being granted; or (3) continuation
of the exemption would not be consistent with the goals and objectives
of 49 U.S.C. 31136(e) and 31315.
Issued on: October 2, 2017.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2017-21897 Filed 10-10-17; 8:45 am]
BILLING CODE 4910-EX-P